How Analysts Feel About Henry Schein, Inc. (NASDAQ:HSIC)?

Henry Schein, Inc. (NASDAQ:HSIC) Logo
Investors sentiment increased to 1.03 in Q4 2018. Its up 0.03, from 1 in 2018Q3. It improved, as 36 investors sold Henry Schein, Inc. shares while 164 reduced holdings. 67 funds opened positions while 139 raised stakes. 151.55 million shares or 1.14% less from 153.30 million shares in 2018Q3 were reported.
Transamerica Advsrs holds 8 shares or 0% of its portfolio. Fiera holds 183,688 shares or 0.05% of its portfolio. Texas Permanent School Fund has 30,661 shares. First Republic Investment Mgmt, a California-based fund reported 45,740 shares. Hsbc Public Limited Company reported 99,720 shares. Moreover, Eulav Asset has 1% invested in Henry Schein, Inc. (NASDAQ:HSIC). Piedmont Advsrs invested in 0.01% or 3,878 shares. Moreover, Stifel Fincl has 0.02% invested in Henry Schein, Inc. (NASDAQ:HSIC) for 66,561 shares. The Ohio-based North Point Portfolio Managers Oh has invested 3.25% in Henry Schein, Inc. (NASDAQ:HSIC). Wells Fargo Mn has invested 0.02% in Henry Schein, Inc. (NASDAQ:HSIC). Pittenger Anderson Incorporated invested 0.3% in Henry Schein, Inc. (NASDAQ:HSIC). Pnc Financial Service Grp Inc stated it has 93,939 shares. Trillium Asset Mngmt Limited Liability Corporation reported 60,056 shares. Bryn Mawr Tru holds 13,135 shares or 0.06% of its portfolio. Country Club Trust Na invested 0.05% in Henry Schein, Inc. (NASDAQ:HSIC).

Since November 30, 2018, it had 1 buy, and 3 sales for $8.47 million activity. $121,190 worth of Henry Schein, Inc. (NASDAQ:HSIC) was bought by Margulies Anne H. on Monday, February 25. McKinley David sold $738,655 worth of stock or 8,321 shares. 21,110 shares were sold by PALADINO STEVEN, worth $1.90 million on Monday, December 3.

Henry Schein, Inc. (NASDAQ:HSIC) Ratings Coverage

Among 8 analysts covering Henry Schein (NASDAQ:HSIC), 3 have Buy rating, 2 Sell and 3 Hold. Therefore 38% are positive. Henry Schein had 12 analyst reports since January 2, 2019 according to SRatingsIntel. The rating was maintained by Robert W. Baird on Monday, March 25 with “Hold”. The rating was maintained by Barrington on Thursday, February 21 with “Buy”. The stock has “Equal-Weight” rating by Barclays Capital on Thursday, February 21. The company was downgraded on Wednesday, January 2 by Robert W. Baird. The rating was maintained by Stifel Nicolaus on Thursday, February 21 with “Hold”. Craig Hallum maintained it with “Buy” rating and $72 target in Tuesday, February 19 report. The firm has “Sell” rating given on Monday, February 25 by UBS. Evercore downgraded the shares of HSIC in report on Thursday, January 3 to “Underperform” rating. The firm has “Hold” rating given on Thursday, February 21 by Robert W. Baird. Below is a list of Henry Schein, Inc. (NASDAQ:HSIC) latest ratings and price target changes.

27/04/2019 Broker: BidaskScore Rating: Hold Upgrade
18/04/2019 Broker: Guggenheim Rating: Buy New Target: $72 Initiates Coverage On
25/03/2019 Broker: Robert W. Baird Rating: Hold New Target: $63 Maintain
25/02/2019 Broker: UBS Rating: Sell New Target: $57 Maintain
21/02/2019 Broker: Stifel Nicolaus Rating: Hold New Target: $65 Maintain
21/02/2019 Broker: Robert W. Baird Rating: Hold New Target: $59 Maintain
21/02/2019 Broker: Barrington Rating: Buy New Target: $72 Maintain
21/02/2019 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $73 New Target: $63 Maintain
19/02/2019 Broker: Craig Hallum Rating: Buy New Target: $72 Maintain
17/01/2019 Broker: UBS Rating: Sell New Target: $73 Initiates Coverage On

The stock increased 1.86% or $1.24 during the last trading session, reaching $67.95. About 1.62 million shares traded. Henry Schein, Inc. (NASDAQ:HSIC) has risen 20.17% since May 8, 2018 and is uptrending. It has outperformed by 15.80% the S&P500.

Henry Schein, Inc. provides health care services and products to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. The company has market cap of $10.16 billion. It operates through two divisions, Health Care Distribution, and Technology and Value-Added Services. It has a 19.47 P/E ratio. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services.

More notable recent Henry Schein, Inc. (NASDAQ:HSIC) news were published by: Seekingalpha.com which released: “Henry Schein Q1 2019 Earnings Preview – Seeking Alpha” on May 06, 2019, also Nasdaq.com with their article: “Why Henry Schein Stock Dropped 27% Today (But Not Really) – Nasdaq” published on February 08, 2019, Nasdaq.com published: “Market Close Report: NASDAQ Composite index closes at 7,963.76 down -159.53 points – Nasdaq” on May 07, 2019. More interesting news about Henry Schein, Inc. (NASDAQ:HSIC) were released by: Nasdaq.com and their article: “Health Care Sector Update for 05/07/2019: PINC,CPRX,HSIC,REGN,SNY – Nasdaq” published on May 07, 2019 as well as Nasdaq.com‘s news article titled: “Henry Schein’s (HSIC) Q1 Earnings, Revenues Beat Estimates – Nasdaq” with publication date: May 07, 2019.

Henry Schein, Inc. (NASDAQ:HSIC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.